Omega3
VITAQ® Omega3 1100 is tested for 83 safety and quality parameters.
ASPRIVA® was not created to be the next supplement brand. Our goal is to simplify scientifically grounded routines. Every formula starts with human studies, benefit-risk assessment, external expertise, rigorous raw material selection and independent laboratory testing.
VITAQ® Omega3 1100 is tested for 83 safety and quality parameters.
Powder products are analyzed for 881 parameters, including 20 nutrition values.
Iterative development with external experts and scientific advisory board.
Human studies are the starting point for formulation development.
Published laboratory reports to make quality verifiable.
ASPRIVA® does not develop formulas from trends. The process combines scientific literature, external review, dosage logic, raw material quality and independent testing.
Review of human studies with defined criteria for substance, dose and application.
Assessment of benefit-risk profile and coherence of the full formula.
Dosages oriented around studied quantities and the logic of daily routines.
Evaluation of origin, purity, quality, authenticity and suitability for use.
Independent laboratory testing for safety and quality, up to 881 parameters per batch.
Relevant results are made available to make quality verifiable.
Our product development begins with human studies. A product is only considered when our scientific advisory board is convinced.
Only ingredients with a clear benefit-risk profile are considered. This applies to selection, combination and dosage.
Every raw material is selected according to purity, quality and authenticity. Only after that do costs, taste and application matter.
Every product is independently tested. Depending on the product, each batch is tested for up to 861 safety and quality parameters.
ASPRIVA® products are not created from trends, advertising promises or simple market analysis. Every formula has to convince our scientific advisory board before it becomes part of an ASPRIVA® routine.
ASPRIVA® Scientific Advisory Board
Biofunctionality of foods, University of Hohenheim
Prof. Dr. Jan Frank holds the chair of Biofunctionality of Foods at the Institute of Nutritional Sciences at the University of Hohenheim. His research focuses on the bioavailability of bioactive plant compounds and the metabolism and function of vitamin E.
Photo: © University of Hohenheim / Arne Hartenburg
CMO, TIBEAY Biosciences
Prof. Dr. John Stover has more than 20 years of experience in clinical and preclinical research, including more than 15 years of clinical experience. He is CMO at TIBEAY Biosciences. Most recently, he was Deputy Chief Medical Officer at B. Braun Group.
Molecular biology, biochemistry and global product development
Dr. Jürgen Kielholz studied molecular biology and biochemistry at the universities of Heidelberg, Hamburg and Basel. He held senior roles in product development and R&D at Beiersdorf, Boots Healthcare, Reckitt Benckiser and Unilever.
The latest articles from the ASPRIVA briefing on longevity, quality and daily routines.
All articles →
Maximum one email per month. 10% discount for subscribing.